AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 225 filers reported holding AMICUS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $127,000 | -0.8% | 13,300 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $128,000 | -2.3% | 13,300 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $131,000 | -80.9% | 13,300 | -55.2% | 0.00% | -82.4% |
| Q4 2020 | $686,000 | +38.6% | 29,708 | -15.3% | 0.02% | -29.2% |
| Q3 2020 | $495,000 | -23.0% | 35,056 | -17.8% | 0.02% | -31.4% |
| Q2 2020 | $643,000 | +3918.8% | 42,672 | +2122.5% | 0.04% | +3400.0% |
| Q3 2019 | $16,000 | +100.0% | 1,920 | +228.8% | 0.00% | – |
| Q1 2019 | $8,000 | -98.3% | 584 | -98.8% | 0.00% | -100.0% |
| Q4 2018 | $479,000 | -80.7% | 50,000 | -75.6% | 0.03% | -77.8% |
| Q3 2018 | $2,479,000 | +76.2% | 204,981 | +127.6% | 0.14% | +61.8% |
| Q2 2018 | $1,407,000 | -39.2% | 90,081 | -41.4% | 0.09% | -47.3% |
| Q1 2018 | $2,313,000 | +185.2% | 153,799 | +172.9% | 0.17% | +160.0% |
| Q4 2017 | $811,000 | -38.7% | 56,348 | -35.8% | 0.06% | -45.8% |
| Q3 2017 | $1,324,000 | -54.7% | 87,800 | -69.7% | 0.12% | -56.5% |
| Q2 2017 | $2,923,000 | +28.8% | 290,199 | -8.8% | 0.28% | +27.2% |
| Q1 2017 | $2,270,000 | +38.1% | 318,369 | -3.8% | 0.22% | +9.0% |
| Q4 2016 | $1,644,000 | -18.1% | 330,956 | +22.0% | 0.20% | -5.2% |
| Q3 2016 | $2,007,000 | +2612.2% | 271,210 | +1894.2% | 0.21% | +2000.0% |
| Q2 2016 | $74,000 | +117.6% | 13,600 | +240.0% | 0.01% | +100.0% |
| Q1 2016 | $34,000 | -83.3% | 4,000 | -80.9% | 0.01% | -84.4% |
| Q4 2015 | $203,000 | +3.6% | 20,900 | +49.3% | 0.03% | +14.3% |
| Q3 2015 | $196,000 | +3.7% | 14,000 | +5.3% | 0.03% | +7.7% |
| Q2 2015 | $189,000 | +30.3% | 13,300 | 0.0% | 0.03% | +30.0% |
| Q1 2015 | $145,000 | +271.8% | 13,300 | +183.0% | 0.02% | +300.0% |
| Q4 2014 | $39,000 | +18.2% | 4,700 | -14.5% | 0.01% | 0.0% |
| Q3 2014 | $33,000 | – | 5,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |